Invega
Links shared publicly online about this topic
Invega Approved as Treatment for Schizophrenia in Adolescents
drugs.com — “Invega (paliperidone) is used to treat schizophrenia and schizoaffective disorder. Includes Invega side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 12, 2011 at 12:14 am By:
Drugs and Devices OW OW Health
Invega Approved as Treatment for Schizophrenia in Adolescents: TITUSVILLE, N.J., April 11, 2011 /PRNewswir... http://bit.ly/e10uNI #drug
INVEGA (Paliperidone) drug information from MPR
empr.com — “INVEGA (Paliperidone) drug information for Schizoaffective disorder, Schizophrenia from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 9, 2011 at 4:45 am By:
MPR News: INVEGA: Indications: added schizophrenia in adolescents. http://bit.ly/AMzNg
FDA approves Invega Sustenna for schizophrenia
news-medical.net — “The U.S. Food and Drug Administration today approved Invega Sustenna (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults.” View full resource at news-medical.net
Most Recently Shared on August 3, 2009 at 2:55 am By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
New long-acting injectable medication approved by the FDA for schizophrenia. #invega http://bit.ly/4pSZiY
INVEGA(R) Approved As Treatment For Schizophrenia In Adolescents
medicalnewstoday.com — “The U.S. Food and Drug Administration (FDA) on April 6 approved INVEGA® (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age. The ef” View full resource at medicalnewstoday.com
Most Recently Shared on April 12, 2011 at 10:05 am By:
INVEGA(R) Approved As Treatment For Schizophrenia In Adolescents http://mnt.to/3TvT #schizophrenia
Invega Sustenna approved for treatment of schizophrenia - MPR
empr.com — “The FDA has approved Invega Sustenna (paliperidone palmitate, from Janssen) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults.” View full resource at empr.com
Most Recently Shared on August 3, 2009 at 4:13 pm By:
MPR News: Invega Sustenna approved for treatment of schizophrenia: The FDA has approved Invega Sustenna.. http://bit.ly/15P18V
Invega Gains Indication for Schizophrenia in Adolescents - MPR
empr.com — “The FDA has approved Invega (paliperidone extended-release tablets; Janssen) for the treatment of schizophrenia in adolescents 12--17 years of age.” View full resource at empr.com
Most Recently Shared on April 11, 2011 at 2:51 pm By:
MPR News: Invega Gains Indication for Schizophrenia in Adolescents: The FDA has approved Invega (paliperidone ex... http://bit.ly/gIMbNx
Invega Gains Indication for Schizophrenia in Adolescents - ONA
oncologynurseadvisor.com — “The FDA has approved Invega (paliperidone extended-release tablets; Janssen) for the treatment of schizophrenia in adolescents 12--17 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 11, 2011 at 2:52 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Invega Gains Indication for Schizophrenia in Adolescents http://goo.gl/fb/9UJfs
Invega approved for treatment of schizoaffective disorder - MPR
empr.com — “Janssen Pharmaceuticals announced the FDA approval of Invega (paliperidone) extended-release tablets for the acute treatment of schizoaffective disorder either as monotherapy or adjunctive therapy to mood stabilizers and/or antidepressants.” View full resource at empr.com
Most Recently Shared on August 3, 2009 at 4:13 pm By:
MPR News: Invega approved for treatment of schizoaffective disorder: Janssen Pharmaceuticals announced .. http://bit.ly/j5PIK
FDA Approves Invega Sustenna for the Acute and Maintenance Treatment of Schizophrenia
drugs.com — “Invega Sustenna (paliperidone palmitate) is used to treat schizophrenia. Includes Invega Sustenna side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 3, 2009 at 11:57 pm By:
FDA Approves Invega Sustenna for the Acute and Maintenance Treatment of Schizophrenia - http://bit.ly/JkPxL
J&J recalls 70,000 Invega syringes | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson said it has recalled 70,000 syringes filled with the antipsychotic drug Invega because of cracks in the syringes.A company spokesman said the issue, discovered” View full resource at reuters.com
Most Recently Shared on February 16, 2011 at 4:22 pm By:
J&J recalls 70,000 Invega syringes http://reut.rs/ghWOcN
Invega Approved as Treatment for Schizophrenia in Teens | Psych Central News
psychcentral.com — “A new drug has been approved for a rare population --teens with schizophrenia. The illness is typically diagnosed first in young adulthood, usually the early” View full resource at psychcentral.com
Most Recently Shared on April 13, 2011 at 6:41 pm By:
News: Invega Approved as Treatment for Schizophrenia in Teens http://bit.ly/dMYdtG
J&J recalls 70,000 Invega syringes | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson said it has recalled 70,000 syringes filled with the antipsychotic drug Invega because of cracks in the syringes.A company spokesman said the issue, discovered” View full resource at reuters.com
Most Recently Shared on February 16, 2011 at 3:27 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
J&J recalls 70,000 Invega syringes http://ow.ly/1bmv9M
Metabolic Effects Significantly Lower With INVEGA(R) Compared To Olanzapine
medicalnewstoday.com — “New data from a 6-month open label randomised controlled trial show INVEGA® (paliperidone ER) is associated with significantly less metabolic effects compared to oral olanzapine in people with” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 1:06 am By:
MNT Clinical Trials Health News
Metabolic Effects Significantly Lower With INVEGA(R) Compared To Olanzapine: New data from a 6-month open label.. http://bit.ly/EoGVw
FDA Approves INVEGA(R) SUSTENNA(TM) For The Acute And Maintenance Treatment Of Schizophrenia
medicalnewstoday.com — “The U.S. Food and Drug Administration approved INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in ad” View full resource at medicalnewstoday.com
Most Recently Shared on August 4, 2009 at 10:36 am By:
psychiatryrounds Psychiatry and Support
FDA Approves INVEGA(R) SUSTENNA(TM) For The Acute And Maintenance Treatment Of Schizophrenia: The U.S. Food and .. http://bit.ly/28t8Q
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU
medicalnewstoday.com — “Janssen-Cilag International NV has received approval from the European Commission for the first antipsychotic treatment for schizoaffective disorder. INVEGA® (paliperidone ER) is now indicate” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2011 at 2:05 pm By:
MNT Depression News Health News
INVEGA® (Paliperidone ER) Approved As First Antipsychotic Treatment For Schizoaffective Disorder In The EU http://mnt.to/3PJm
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
Advertisement
